Tech Company Financing Transactions
Ceribell Funding Round
Ceribell secured a $35 million Series B funding round on 9/27/2018. Backers included Optimas Capital Partners Fund, The Rise Fund and LivaNova.
Transaction Overview
Company Name
Announced On
9/27/2018
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
Optimas Capital Partners Fund (Lead Investor) (Yongzhi Jiang)
The Rise Fund (Lead Investor)
Proceeds Purpose
Proceeds will be used to expand commercialization of its innovative Rapid Response EEG System to improve the diagnosis and treatment of patients at risk for seizures.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2483 Old Middlefield Way 120
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. We've created and validated an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jane Chao
Chief Financial Officer
Scott Blumberg
Chief Technical Officer
Raymond Woo
VP - Marketing
Rafael Donnay
VP - Operations
Daniel Rogy
VP - Sales
Les Burrows
Browse more venture capital transactions:
Prev: 9/27/2018: Plant Prefab venture capital transaction
Next: 9/27/2018: Rational Vaccines venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs